Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

7.6K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genome-wide transcriptome profiling in crossbred pigs after challenge with Classical Swine Fever Virus.

Microbial pathogenesis·2026
Same author

Eco-technological potential of salinity-driven functional specialization in Indian solar salterns revealed by integrated culturomics and whole-metagenome profiling.

BMC microbiology·2026
Same author

Correction: Integrated methylome-transcriptome profiling reveals epigenetic regulation of immune activation pathways and CSN3-associated lactation repression in bovine subclinical mastitis.

Journal of animal science and biotechnology·2026
Same author

Prevalence of diarrhoeal cases and deaths associated with food-borne illnesses in India: a systematic review and meta-analysis.

Journal of infection in developing countries·2026
Same author

Integrated methylome-transcriptome profiling reveals epigenetic regulation of immune activation pathways and CSN3-associated lactation repression in bovine subclinical mastitis.

Journal of animal science and biotechnology·2026
Same author

Wheat's war against stripe rust: Integrating host immunity, genomics and breeding for durable resistance.

The plant genome·2026

Related Experiment Video

Updated: Aug 22, 2025

TGF-β-mediated Endothelial to Mesenchymal Transition EndMT and the Functional Assessment of EndMT Effectors using CRISPR/Cas9 Gene Editing
07:05

TGF-β-mediated Endothelial to Mesenchymal Transition EndMT and the Functional Assessment of EndMT Effectors using CRISPR/Cas9 Gene Editing

Published on: February 26, 2021

5.3K

YAP/TAZ Mediate TGFβ2-Induced Schlemm's Canal Cell Dysfunction.

Haiyan Li1,2, Ayushi Singh1,2, Kristin M Perkumas3

  • 1Department of Ophthalmology and Visual Sciences, SUNY Upstate Medical University, Syracuse, New York, United States.

Investigative Ophthalmology & Visual Science
|November 9, 2022
PubMed
Summary
This summary is machine-generated.

Elevated TGFβ2 in glaucoma disrupts Schlemm

More Related Videos

Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay
11:38

Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay

Published on: September 14, 2021

3.5K
Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling
07:49

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling

Published on: August 3, 2018

11.4K

Related Experiment Videos

Last Updated: Aug 22, 2025

TGF-β-mediated Endothelial to Mesenchymal Transition EndMT and the Functional Assessment of EndMT Effectors using CRISPR/Cas9 Gene Editing
07:05

TGF-β-mediated Endothelial to Mesenchymal Transition EndMT and the Functional Assessment of EndMT Effectors using CRISPR/Cas9 Gene Editing

Published on: February 26, 2021

5.3K
Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay
11:38

Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay

Published on: September 14, 2021

3.5K
Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling
07:49

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling

Published on: August 3, 2018

11.4K

Area of Science:

  • Ocular Biology
  • Cellular Mechanotransduction
  • Glaucoma Pathophysiology

Background:

  • Elevated transforming growth factor beta2 (TGFβ2) in aqueous humor is associated with glaucomatous outflow tissue dysfunction.
  • Yes-associated protein (YAP) and transcriptional coactivator with PDZ binding motif (TAZ) are potential mediators of this dysfunction.
  • The precise mechanisms of YAP/TAZ regulation in Schlemm's canal (SC) cells under glaucomatous conditions remain unclear.

Purpose of the Study:

  • To investigate how TGFβ2 modulates YAP/TAZ activity in human SC (HSC) cells.
  • To examine the potential of pharmacological YAP/TAZ inhibition to counteract TGFβ2-induced HSC cell dysfunction.

Main Methods:

  • HSC cells were cultured on or within biomimetic extracellular matrix hydrogels.
  • Cells were treated with TGFβ2, with or without actin destabilization or YAP/TAZ inhibition (verteporfin).
  • Assessed changes in actin cytoskeleton, YAP/TAZ nuclear localization, extracellular matrix production, and hydrogel contraction.

Main Results:

  • TGFβ2 increased YAP/TAZ nuclear localization in HSC cells, which was mitigated by actin cytoskeleton modulation.
  • Verteporfin treatment reduced fibronectin expression and actomyosin rearrangement induced by TGFβ2.
  • Pharmacological YAP/TAZ inhibition attenuated TGFβ2-induced hydrogel contraction by HSC cells.

Conclusions:

  • Aberrant YAP/TAZ signaling plays a pathological role in HSC cells under simulated glaucomatous conditions.
  • Pharmacological YAP/TAZ inhibition shows promise for treating outflow tissue dysfunction in glaucoma.
  • Targeting YAP/TAZ signaling may offer a novel therapeutic strategy for glaucoma management.